These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1800944)

  • 21. An electromyographic method for the assessment of naloxone-induced abstinence in morphine-dependent rats.
    Menon MK; Tseng LF; Loh HH; Clark WG
    Naunyn Schmiedebergs Arch Pharmacol; 1980 May; 312(1):43-9. PubMed ID: 7190227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of neuropeptide FF (NPFF) in the expression of sensitization to hyperlocomotor effect of morphine and ethanol.
    Kotlinska J; Pachuta A; Dylag T; Silberring J
    Neuropeptides; 2007 Feb; 41(1):51-8. PubMed ID: 17107711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats.
    Aricioglu-Kartal F; Uzbay IT
    Life Sci; 1997; 61(18):1775-81. PubMed ID: 9365224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A subtype-specific neuropeptide FF receptor antagonist attenuates morphine and nicotine withdrawal syndrome in the rat.
    Malin DH; Henceroth MM; Elayoubi J; Campbell JR; Anderson A; Goyarzu P; Izygon J; Madison CA; Ward CP; Burstein ES
    Neurosci Lett; 2018 Sep; 684():98-103. PubMed ID: 29981879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dependence and withdrawal following intracerebroventricular and systemic morphine administration: functional anatomy and behavior.
    Adams RE; Wooten GF
    Brain Res; 1990 Jun; 518(1-2):6-10. PubMed ID: 2390728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three different types of alpha-interferons alter naloxone-induced abstinence in morphine-addicted rats.
    Dafny N; Reyes-Vazquez C
    Immunopharmacology; 1985 Feb; 9(1):13-7. PubMed ID: 4039302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat.
    Oberling P; Stinus L; Le Moal M; Simonnet G
    Peptides; 1993; 14(5):919-24. PubMed ID: 8284268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide FF (FLQPQRFamide) and IgG from neuropeptide FF antiserum affect spatial learning in mice.
    Kavaliers M; Colwell DD
    Neurosci Lett; 1993 Jul; 157(1):75-8. PubMed ID: 8233035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence.
    Wang Z; Bilsky EJ; Porreca F; Sadée W
    Life Sci; 1994; 54(20):PL339-50. PubMed ID: 7514710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of withdrawal in reinstatement of morphine-conditioned place preference.
    Lu L; Chen H; Su W; Ge X; Yue W; Su F; Ma L
    Psychopharmacology (Berl); 2005 Aug; 181(1):90-100. PubMed ID: 15739075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enkephalinase inhibitors attenuate naloxone-precipitated withdrawal syndrome.
    Dzoljic MR
    NIDA Res Monogr; 1986; 75():575-8. PubMed ID: 3123978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies directed against the mu-opioid receptor alleviated multiple signs of morphine withdrawal in mice.
    Sánchez-Blázquez P; Rodríguez MD; Garzón J
    Life Sci; 1996; 59(8):PL87-92. PubMed ID: 8761021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naloxone-precipitated abstinence in mice, rats and gerbils acutely dependent on morphine.
    Ramabadran K
    Life Sci; 1983; 33 Suppl 1():385-8. PubMed ID: 6686634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
    Wang HL; Xiang XH; Guo Y; Wu WR; Cao DY; Wang HS; Zhao Y
    Eur J Pharmacol; 2005 Dec; 527(1-3):94-104. PubMed ID: 16303124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of calcitonin on morphine tolerance and withdrawal syndrome in morphine physically dependent rats.
    Clementi G; Valerio C; Prato A; Caruso A; Patti F; Patanè S; Drago F
    Eur J Pharmacol; 1989 Apr; 163(1):175-9. PubMed ID: 2744091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auricular microelectrostimulation: naloxone-reversible attenuation of opiate abstinence syndrome.
    Malin DH; Murray JB; Crucian GP; Schweitzer FC; Cook RE; Skolnick MH
    Biol Psychiatry; 1988 Dec; 24(8):886-90. PubMed ID: 2852967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central sites of naloxone-precipitated shaking in the anesthetized, morphine-dependent rat.
    Wei E; Sigel SS; Loh HH; Way EL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):480-7. PubMed ID: 1238555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of divalent ions on morphine analgesia and abstinence syndrome in morphine-tolerant and -dependent mice.
    Bhargava HN
    Psychopharmacology (Berl); 1978 Apr; 57(2):223-5. PubMed ID: 418458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of the expression of naloxone-precipitated withdrawal signs in morphine-dependent mice by diabetes: possible involvement of protein kinase C.
    Ohsawa M; Kamei J
    Jpn J Pharmacol; 1999 Mar; 79(3):303-11. PubMed ID: 10230858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropeptide FF receptors: structure-activity relationship and effect of morphine.
    Payza K; Akar CA; Yang HY
    J Pharmacol Exp Ther; 1993 Oct; 267(1):88-94. PubMed ID: 8229791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.